Roy Freeman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Roy Freeman
Roy Freeman was last confirmed as Board Member at Inhibikase Therapeutics, Inc. (IKT) in a filing dated May 12, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-05-12
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
No call appearances or filed executive changes recorded yet.